Xtant Medical Holdings, Inc.
XTNT · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $117,267 | $91,303 | $57,969 | $55,263 |
| % Growth | 28.4% | 57.5% | 4.9% | – |
| Cost of Goods Sold | $49,051 | $35,836 | $25,832 | $22,773 |
| Gross Profit | $68,216 | $55,467 | $32,137 | $32,490 |
| % Margin | 58.2% | 60.8% | 55.4% | 58.8% |
| R&D Expenses | $2,385 | $1,336 | $915 | $870 |
| G&A Expenses | $28,691 | $25,850 | $15,462 | $14,449 |
| SG&A Expenses | $77,905 | $64,289 | $37,977 | $35,474 |
| Sales & Mktg Exp. | $49,214 | $38,439 | $22,515 | $21,025 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $80,290 | $65,625 | $38,892 | $36,344 |
| Operating Income | -$12,074 | -$10,158 | -$6,755 | -$3,854 |
| % Margin | -10.3% | -11.1% | -11.7% | -7% |
| Other Income/Exp. Net | -$4,188 | $9,121 | -$1,661 | -$995 |
| Pre-Tax Income | -$16,262 | -$1,037 | -$8,416 | -$4,849 |
| Tax Expense | $187 | -$1,697 | $69 | $0 |
| Net Income | -$16,449 | $660 | -$8,485 | -$4,849 |
| % Margin | -14% | 0.7% | -14.6% | -8.8% |
| EPS | -0.12 | 0.006 | -0.09 | -0.057 |
| % Growth | -2,281.8% | 106.1% | -59.1% | – |
| EPS Diluted | -0.12 | 0.005 | -0.09 | -0.057 |
| Weighted Avg Shares Out | 133,665 | 119,094 | 94,085 | 85,456 |
| Weighted Avg Shares Out Dil | 133,665 | 126,793 | 94,085 | 85,456 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $149 | $31 | $0 |
| Interest Expense | $4,160 | $2,938 | $1,692 | $995 |
| Depreciation & Amortization | $4,224 | $3,174 | $1,296 | $1,341 |
| EBITDA | -$7,878 | $5,075 | -$5,428 | -$2,513 |
| % Margin | -6.7% | 5.6% | -9.4% | -4.5% |